| |
 |
|
Class Information
Number: 514/274
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,3-diazines (e.g., pyrimidines, etc.) > Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety > Chalcogen bonded directly to pyrimidine at 2-position
Description: Subject matter wherein a chalcogen is directly bonded to the 2-position of the pyrimidine.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615569 |
Inhibitors of ion channels |
Nov. 10, 2009 |
| 7615542 |
Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV |
Nov. 10, 2009 |
| 7612093 |
Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy |
Nov. 3, 2009 |
| 7608618 |
Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1 |
Oct. 27, 2009 |
| 7605137 |
Combination therapy comprising cloretazine |
Oct. 20, 2009 |
| 7601730 |
Carboxylic acid derivatives, their preparation and use |
Oct. 13, 2009 |
| 7592353 |
Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
Sep. 22, 2009 |
| 7582647 |
Carboxylic acid derivatives, their preparation and use |
Sep. 1, 2009 |
| 7569575 |
Synthesis of locked nucleic acid derivatives |
Aug. 4, 2009 |
| 7566724 |
Glycine derivative and use thereof |
Jul. 28, 2009 |
| 7563788 |
Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents |
Jul. 21, 2009 |
| 7560483 |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
Jul. 14, 2009 |
| 7560467 |
Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
Jul. 14, 2009 |
| 7560466 |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
Jul. 14, 2009 |
| 7557138 |
5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel |
Jul. 7, 2009 |
| 7544692 |
Polymorphic and other crystalline forms of cis-FTC |
Jun. 9, 2009 |
| 7531536 |
Pyrazole compounds useful as protein kinase inhibitors |
May. 12, 2009 |
| 7528142 |
Aminopyrimidines useful as kinase inhibitors |
May. 5, 2009 |
| 7517889 |
2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists |
Apr. 14, 2009 |
| 7511051 |
Cidofovir peptide conjugates as prodrugs |
Mar. 31, 2009 |
| 7511027 |
Method of treating hepatitis delta virus infection |
Mar. 31, 2009 |
| 7495006 |
2' and 3'-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
Feb. 24, 2009 |
| 7482356 |
Bicyclic pyrazolone cytokine inhibitors |
Jan. 27, 2009 |
| 7482355 |
Pyrimidine derivatives as modulators of chemokine receptor activity |
Jan. 27, 2009 |
| 7473695 |
4-imidazolin-2-one compounds |
Jan. 6, 2009 |
| 7470686 |
Method of inhibiting the expression and/or the activity of JNK |
Dec. 30, 2008 |
| 7470672 |
Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
Dec. 30, 2008 |
| 7465736 |
Azole methylidene cyanide derivatives and their use as protein kinase modulators |
Dec. 16, 2008 |
| 7465735 |
5-Phenypyrimidines their preparation compositions comprising them and their use |
Dec. 16, 2008 |
| 7452898 |
Phosphonate compounds |
Nov. 18, 2008 |
| 7452879 |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
Nov. 18, 2008 |
| 7419983 |
Gonadotropin-releasing hormone receptor antagonists and methods related thereto |
Sep. 2, 2008 |
| 7402588 |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
Jul. 22, 2008 |
| 7384924 |
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
Jun. 10, 2008 |
| 7378446 |
Compound having anti-HCV activity and process for producing the same |
May. 27, 2008 |
| 7368456 |
Methods, compositions, and kits for organ protection during systemic anticancer therapy |
May. 6, 2008 |
| 7368455 |
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
May. 6, 2008 |
| 7364752 |
Solid dispersion pharamaceutical formulations |
Apr. 29, 2008 |
| 7361654 |
Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof |
Apr. 22, 2008 |
| 7358239 |
Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
Apr. 15, 2008 |
| 7354928 |
Small molecule inhibitors targeted at Bcl-2 |
Apr. 8, 2008 |
| 7345046 |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
Mar. 18, 2008 |
| 7345039 |
Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
Mar. 18, 2008 |
| 7335657 |
Cytokine inhibitors |
Feb. 26, 2008 |
| 7329669 |
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
Feb. 12, 2008 |
| 7326714 |
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
Feb. 5, 2008 |
| 7317014 |
Bio-active pyrimidine molecules |
Jan. 8, 2008 |
| 7312209 |
Acridone inhibitors of IMPDH enzyme |
Dec. 25, 2007 |
| 7297694 |
Pyridylfurans and pyrroles as Raf kinase inhibitors |
Nov. 20, 2007 |
| 7294627 |
Chemical compounds |
Nov. 13, 2007 |
|
|
|
